Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N8JA
|
|||
| Former ID |
DIB009185
|
|||
| Drug Name |
Theradigm-HBV
|
|||
| Synonyms |
CY-1899; Theradigm-hepatitis B virus
Click to Show/Hide
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Discontinued in Phase 2 | [1] | |
| Company |
Genencor International Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Major histocompatibility complex (MHC) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004156) | |||
| REF 2 | Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology. 1997 Oct;26(4):1027-34. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.